Federation Des Caisses Desjardins Du Quebec Enanta Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.4 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 30, 2024	SELL	$46.37 - $57.58 $40,156 - $49,864	-866 Closed	0 $0
Q1 2020 Aug 30, 2024	SELL	$40.22 - $62.0 $208,822 - $321,904	-5,192 Reduced 85.7%	866 $45.1 Million
Q4 2018 Aug 30, 2024	BUY	$65.41 - $84.65 $396,253 - $512,809	6,058 New	6,058 $430 Million
Q1 2018 Aug 30, 2024	BUY	$57.91 - $92.15 $350,818 - $558,244	6,058 New	6,058 $490 Million
Q4 2017 Aug 30, 2024	SELL	$45.65 - $59.37 $45,650 - $59,370	-1,000 Closed	0 $0
Q2 2017 Aug 30, 2024	SELL	N/A	-858 Reduced 46.18%	1,000 $36 Million
Q1 2017 Aug 30, 2024	BUY	N/A	1,858	1,858 $57.2 Million

Others Institutions Holding ENTA

# of Institutions

108

Shares Held

19.7M

Call Options Held

9.7K

Put Options Held

12.4K

Krensavage Asset Management, LLC New York, NY

2.12M
Shares

$15 Million
7.2% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$15 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$14.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$13.1 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.22M
Shares

$8.67 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $147M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account